Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on September 22, 2003

Circulation. 2003
Published online before print September 22, 2003, doi: 10.1161/01.CIR.0000094737.21775.32
A more recent version of this article appeared on October 14, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
108/15/1798    most recent
01.CIR.0000094737.21775.32v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, S. S.-l.
Right arrow Articles by Yiu, S.-f.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, S. S.-l.
Right arrow Articles by Yiu, S.-f.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*METHYLPREDNISOLONE
*RIBAVIRIN
Medline Plus Health Information
*Severe Acute Respiratory Syndrome
Related Collections
Right arrow Other heart failure
Right arrow Echocardiography

© American Heart Association, Inc.

Clinical Investigation and Reports

Left Ventricular Performance in Patients With Severe Acute Respiratory Syndrome

A 30-Day Echocardiographic Follow-Up Study

Steven Siu-lung Li, MBBS; Cheung-wah Cheng, MBBS; Chiu-lai Fu, MBBS; Yiu-han Chan, MBChB; Man-po Lee, MBBS; Johnny Wai-man Chan, MBBS Siu-fung Yiu, MBBS

From the Division of Cardiology (S.S.L., C.C., C.F., S.Y.) and Division of Respiratory Medicine (Y.C., M.L., J.W.C.), Department of Medicine, Queen Elizabeth Hospital, Hong Kong.

Correspondence to Dr Steven Siu-Lung Li, Division of Cardiology, Department of Medicine, Queen Elizabeth Hospital, 30 Gascoigne Road, Kowloon, Hong Kong. E-mail listevensl{at}yahoo.com

Received June 25, 2003; de novo received July 25, 2003; revision received August 20, 2003; accepted August 20, 2003.

Background— Severe acute respiratory syndrome (SARS) is characterized by an overaggressive immune response. Myocardial performance may be impaired in cytokine-mediated immune reactions.

Methods and Results— Forty-six patients with established clinical diagnosis of SARS were studied prospectively. Transthoracic echocardiographic examinations were done at the acute stage of infection and 30 days later. Among them, 14 patients required mechanical ventilation. The clinical course, laboratory data, SARS-CoV antibody titers, and results of reverse transcriptase–polymerase chain reaction were studied. Significantly higher left ventricular index of myocardial performance (IMP) (0.42±0.13 versus 0.33±0.09, P<0.001), longer isovolumic relaxation time (102.9±15.7 versus 81.6±14.7 ms, P<0.001), lower flow propagation velocity (69.6±15.7 versus 83.8±19.7 cm/s, P=0.011), and Doppler-derived cardiac output (4.69±1.01 versus 5.49±1.04 L/min, P<0.001) were observed during acute infection when compared with those at 30 days. No significant valvular disease or pulmonary hypertension was found. At baseline, a lower mean left ventricular ejection fraction (LVEF) (65.3±12.8% versus 71.4±5.7%, P=0.03) and a higher mean IMP (0.51±0.11 versus 0.40±0.12, P=0.017) were found in patients who required mechanical ventilation. A decrease in LVEF correlated moderately with an elevated lactate dehydrogenase level (r=-0.605, P<0.001), whereas a higher IMP correlated weakly with an increase in creatine kinase level (r=0.38, P=0.016). Histological examination of the heart in the patient with the lowest EF (30.2%) revealed no interstitial lymphocytic infiltrate or myocyte necrosis.

Conclusions— Subclinical diastolic impairment without systolic involvement was observed in patients with SARS. This impairment may be reversible on clinical recovery.


Key Words: diastole • echocardiography • myocardial contraction




This article has been cited by other articles:


Home page
Clin. Microbiol. Rev.Home page
V. C. C. Cheng, S. K. P. Lau, P. C. Y. Woo, and K. Y. Yuen
Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection
Clin. Microbiol. Rev., October 1, 2007; 20(4): 660 - 694.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
C C W Yu, A M Li, R C H So, A McManus, P C Ng, W Chu, D Chan, F Cheng, W K Chiu, C W Leung, et al.
Longer term follow up of aerobic capacity in children affected by severe acute respiratory syndrome (SARS)
Thorax, March 1, 2006; 61(3): 240 - 246.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
D S C Hui, M C H Chan, A K Wu, and P C Ng
Severe acute respiratory syndrome (SARS): epidemiology and clinical features
Postgrad. Med. J., July 1, 2004; 80(945): 373 - 381.
[Abstract] [Full Text] [PDF]


Home page
JWatch GeneralHome page
Cardiac Performance in SARS Patients
Journal Watch (General), November 25, 2003; 2003(1125): 3 - 3.
[Full Text]